Dr. Daniel J. Lovestrand, MD

Dr. Lovestrand practices at WellSpan Evangelical Community Hospital in Lewisburg, Pennsylvania, part of WellSpan Health.

Dr. Lovestrand's NPI, 1164531208, was assigned on August 30, 2006. Dr. Lovestrand holds Pennsylvania license MD041019L.

Dr. Lovestrand's primary practice is WellSpan Evangelical Community Hospital, at One Hospital Drive, Lewisburg, PA 17837 in Union County. The practice phone is (570) 522-2000. Dr. Lovestrand also practices at Evangelical Community Hospital, 1 Hospital Dr, Lewisburg, PA 17837.

Dr. Lovestrand's primary practice is WellSpan Evangelical Community Hospital in Lewisburg, Pennsylvania, part of WellSpan Health. Dr. Lovestrand is also affiliated with Geisinger Medical Center. The medical group on file is WellSpan Digestive Health. Dmand AI also links Dr. Lovestrand to 1 more clinical lab and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lovestrand practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Lovestrand's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Lovestrand is licensed in Pennsylvania.

CMS data shows 448 Medicare services from Dr. Lovestrand across 4 procedure codes in 2024, for 227 Medicare patients. Medicare paid $38,133 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 227 Medicare patients who saw Dr. Lovestrand in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lovestrand's median patient age at 79, with 54% women.

In 2024, Dr. Lovestrand wrote 293 Medicare Part D claims for 124 patients. 90% of them were for generic drugs. CMS names the drug for 73 of them, across 4 drugs with 11 or more claims each, at $657 in total drug cost. In 2023, CMS named 79 claims across 6 drugs.

Dr. Lovestrand accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 15 general payments to Dr. Lovestrand from 9 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $241.